CAS 100021-05-4

Formula: C21H28O2

InChI: InChI=1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,5,16-19,23H,3,6-13H2,1H3/t16-,17+,18+,19-,20-,21-/m0/s1

InChI key: LYRBZVWRTAFWPO-XUDSTZEESA-N

SMILES: CC[C@]12CC[C@@H]3[C@H]4CCC(=O)CC4=CC[C@H]3[C@@H]1CC[C@]2(C#C)O

Levonorgestrel EP Impurity P

CAS: 100021-05-4

Formula: C₂₁H₂₈O₂

Colore e forma: White To Off-White Solid

Peso molecolare: 312.45

Ref: 4Z-L-2210

5(6)-Dehydro-4(5)-dihydro D-(-)-Norgestrel (>90%)

Prodotto controllato

CAS: 100021-05-4

Impurity Levonorgestrel EP Impurity P
Applications 5(6)-Dehydro-4(5)-dihydro D-(-)-Norgestrel (Levonorgestrel EP Impurity P) is a Norgestrel (N689500) impurity.

Formula: C₂₁H₂₈O₂

Purezza: >90%

Colore e forma: Neat

Peso molecolare: 312.45

Ref: TR-D229935

(17a)-13-Ethyl-17-hydroxy-18,19-dinorpregn-5-en-20-yn-3-one

Prodotto controllato

CAS: 100021-05-4

(17a)-13-Ethyl-17-hydroxy-18,19-dinorpregn-5-en-20-yn-3-one is a progestin that acts as an inhibitor of the P450 enzyme. It has been used in the treatment of women with fertility problems. (17a)-13-Ethyl-17-hydroxy-18,19-dinorpregn-5-en--20--yn--3--one has shown inhibitory effects on voltage dependent calcium channels and thus may have contraceptive properties. It has also been shown to be effective in the long term treatment of intrauterine devices. Low bioavailability is a disadvantage of this drug.br>br>

Formula: C₂₁H₂₈O₂

Purezza: Min. 95%

Colore e forma: Powder

Peso molecolare: 312.45 g/mol

Ref: 3D-FE20961

Levonorgestrel EP Impurity P

CAS: 100021-05-4

Formula: C₂₁H₂₈O₂

Peso molecolare: 312.45

Ref: ST-EA-CP-L19016